期刊文献+

艾司西酞普兰与文拉法辛治疗抑郁症对照研究 被引量:6

Controlled study of escitalopram and venlafaxine in treatment of depression
下载PDF
导出
摘要 目的:比较艾司西酞普兰与文拉法辛治疗抑郁症的疗效与安全性。方法:采用艾司西酞普兰与文拉法辛对48例抑郁症患者进行为期6周的双盲对照研究,用汉密尔顿抑郁量表(HAMD)、临床疗效总评量表(CGI)在治疗前及治疗1、2、4、6周评定疗效;用治疗中出现的症状量表(TESS)评定不良反应。结果:治疗6周后艾司西酞普兰组与文拉法辛组的有效率分别为87.50%和83.33%,两组差异无显著性。2药起效均较快,不良反应均较轻。结论:艾司西酞普兰与文拉法辛均是安全有效的抗抑郁药。 Objective: To compare the efficacy and tolerability between escitalopram and venlafaxine in the treantment of depression. Method : Forty-eight patients with depression were double-blindly assigned to escitalopram and venlafaxine for 6 weeks. The efficacy of all the patients were assessed with Hamilton depressive scale(HAMD) and the clinical global impression scale(CGI) before treatment and at the end of 1st,2nd,4th, 6th week treatment,and the side effects were evaluated with the treatment emergent symptom scale (TESS). Results: After 6 weeks treatment, the effective rates of escitalopram group and venlafaxine group were 87.50% and 83.33% respectively. There was no significant difference between two groups. Both drugs took effect quickly. Conclusion: Both escitalopram and venlafaxine are effective and safe antidepressants.
作者 赵海英
出处 《临床精神医学杂志》 2008年第5期343-344,共2页 Journal of Clinical Psychiatry
关键词 艾司西酞普兰 文拉法辛 抑郁症 escitalopram venlafaxine depression
  • 相关文献

参考文献8

  • 1司天梅,舒良.关于新抗抑郁药艾司西酞普兰[J].临床精神医学杂志,2007,17(1):68-69. 被引量:124
  • 2Murdoch D,Keam SJ. Escitalopram:a review of its use in the management of major depressive disorder [ J ]. Drugs, 2005,65 : 2379- 2404.
  • 3Gorman JM, Korotzer A, Su G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder:pooled analysis of placebo-controlled trials [ J ]. CNS Spectr, 2002,7 ( Suppl) :40-44.
  • 4Bielski RJ, Ventura D, Chang CC. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder [ J ].J Clin Psychiatry, 2004, 65 : 1190- 1196.
  • 5Montgomery SA, Huusom AKT, Bothmer J. A randomized study comparing escitalopram with velafaxine XR in primary care patients with major depressive disorder[ J]. Neuropsychobiology ,2004,50 : 57 -64.
  • 6Fernandez JL, Montgomery S, Francois C. Evaluation of the cost effectiveness of escitalopiam versus venlafaxine XR in major depressive disorder[ J]. Pharmacoeconomics,2005,23 : 155-167.
  • 7王雪艳,孙波,张永东,刘瑞华,王立钢,王克.艾司西酞普兰与马普替林治疗抑郁症对照研究[J].临床精神医学杂志,2007,17(5):324-324. 被引量:11
  • 8李进,申文武,刘阳,徐理,刘善明,况伟宏.艾司西酞普兰治疗抑郁症有效性和安全性的随机双盲阳性药物对照试验[J].中国循证医学杂志,2006,6(8):552-556. 被引量:34

二级参考文献22

  • 1王玉伟,杨丽芹,孙静,邵长春.西酞普兰与氟西汀治疗抑郁症对照研究[J].临床精神医学杂志,2004,14(4):225-226. 被引量:69
  • 2Montgomery SA.Clinically relevant effect sizes in depresion.Eur Neuropsychopharcol.1994; 4(4):283-284.
  • 3Hyttel J,Bogeso KP,Perregaard J,et al.The pharmacological effect of citalopram residues in the(S)-(+)-enantionmer.J Neural Transm Gen Sect,1992;88(2):157-159.
  • 4Owen MJ,Knight DL,Nemerof CB.Second generation SSRIs:human monioamine transporter blinding profile of esitapram and R-fluoxetine.Bio Psychiatry,2001; 50(5):345-350.
  • 5Von Moltke LL,Greenblatt DJ,Giancarlo GM,et al.Escitalopram(Scitalopram)and its metabolites in vitro:cytochromes mediating biotransformation,inhibitory effects,and comparison to R-citalopram.Drug Metab Dispos,2001; 29(9):1102-1109.
  • 6Burke WJ,Gergel I,Bose A.Fixed-dose trial of the single isomer SSRI Escitalopram in depressed outpatients.J Clin Psychiatry,2002; 63(4):331-339.
  • 7Lepola UM,Loft H,Reines EH.Escitalopram is effective and well tolerated in a placebo-controlled study in depression in primary care.lnt Clin Psychopharmacol,2003; 18(4):211-220.
  • 8Owens MJ,Knight DL,Nemeroff CB.Second generation SSRIs:human monoamine transporter binding profile of escitalopram and R-fluoxetine[J].Biol Psychiatry,2001,50:345-350.
  • 9Chen FH,Larsen MB,Sanchezc,et al.The S-enantiomer of R,S-citalopram,increases inhibitor binding to the human serotonin transporter by an allosteric mechanism.Comparison with other serotonin transporter inhibitors[J].Eur Neuropsychopharmacology,2005,15:193-198.
  • 10Mork A,Kreilgaard M,Sanchez C.The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats[J].Neuropharmacology,2003,45:167-173.

共引文献145

同被引文献54

引证文献6

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部